- •It is difficult to classify fibrinogen disorders by Clauss fibrinogen assay (CFA) alone.
- •We developed clot waveform analysis (CWA) to distinguish fibrinogen abnormalities.
- •We found the “Min1” value to be a surrogate marker for fibrinogen antigen.
- •CWA of CFA could be a novel screening test for fibrinogen disorders.
Materials and methods
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Congenital fibrinogen disorders: an update.Semin. Thromb. Hemost. 2013; 39: 585-595
- Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management.J. Thromb. Haemost. 2015; 13: 909-919
- Rapid physiological coagulation method in determination of fibrinogen.Acta Haematol. 1957; 17: 237-246
- Evaluation of a fully automated centrifugal analyzer for performance of hemostasis tests.Clin. Chem. 1987; 33: 1888-1890
- Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers.Thromb. Res. 1988; 52: 453-468
- Optimal monitoring of bypass therapy in hemophilia a patients with inhibitors by the use of clot waveform analysis.J. Thromb. Haemost. 2014; 12: 355-362
- New quantitative aPTT waveform analysis and its application in laboratory management of haemophilia a patients.Haemophilia. 2014; 20: 898-904
- Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH.J. Thromb. Haemost. 2018; 16: 1887-1890
- Towards standardization of clot waveform analysis and recommendations for its clinical applications.J. Thromb. Haemost. 2013; 11: 1417-1420
- New assays for monitoring haemophilia treatment.Haemophilia. 2008; 14: 83-92
- Early identification and prognostic implications in disseminated intravascular coagulation through transmittance waveform analysis.Thromb. Haemost. 1998; 80: 65-69
- Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca++-dependent complex of C-reactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation.Blood. 2002; 100: 2522-2529
- Comparison of the kinetic fibrinogen assay with the von Clauss method and the clot recovery method in plasma of patients with conditions affecting fibrinogen coagulability.Am. J. Clin. Pathol. 1995; 104: 455-462
- The amplitude of coagulation curves from thrombin time tests allows dysfibrinogenemia caused by the common mutation FGG-Arg301 to be distinguished from hypofibrinogenemia.Int. J. Lab. Hematol. 2017; 39: 301-307
- Screening of dysfibrinogenaemia using the fibrinogen function versus antigen concentration ratio.Thromb. Res. 1994; 76: 577-579
- Natural history of patients with congenital dysfibrinogenemia.Blood. 2015; 125: 553-561
- Clinical phenotype, laboratory features and genotype of 35 patients with heritable dysfibrinogenaemia.Br. J. Haematol. 2013; 160: 220-227
- Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia.Thromb. Res. 2010; 126: e428-e433
- Dysfibrinogenemia (fibrinogen Wilmington) due to a novel Aalpha chain truncation causing decreased plasma expression and impaired fibrin polymerisation.Thromb. Haemost. 2006; 96: 88-89
- A Bbeta 14 Arg → Cys fibrinogen variant in a patient with thrombotic complications (fibrinogen St-Germain III).J. Thromb. Haemost. 2006; 4: 2722-2723
- Demonstration of heterodimeric fibrinogen molecules partially conjugated with albumin in a novel dysfibrinogen: fibrinogen Mannheim V.Thromb. Haemost. 2009; 102: 29-34